Related references
Note: Only part of the references are listed.ClearCell® FX, a label-free microfluidics technology for enrichment of viable circulating tumor cells
Yifang Lee et al.
CYTOMETRY PART A (2018)
Succinct workflows for circulating tumor cells after enrichment: From systematic counting to mutational profiling
Victor Chun-Lam Wong et al.
PLOS ONE (2017)
Prognostic value of circulating tumor cells in metastatic breast cancer: a systemic review and meta-analysis
Q. Lv et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
Molecular characterization of PDL1 status of circulating tumor cells (CTCs) isolated with a novel label-free inertial microfluidic system from patients (pts) with advanced cancers
J. Fraser-Fish et al.
ANNALS OF ONCOLOGY (2016)
Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation
Marta Tellez Gabriel et al.
CLINICAL CHEMISTRY (2016)
Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistance
Costanza Paoletti et al.
MOLECULAR ONCOLOGY (2016)
Prognostic Impact of Circulating Tumor Cell Detected Using a Novel Fluidic Cell Microarray Chip System in Patients with Breast Cancer
Takeshi Sawada et al.
EBIOMEDICINE (2016)
Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas
Daniel L. Adams et al.
BREAST CANCER RESEARCH (2016)
The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients
Markus Wallwiener et al.
BMC CANCER (2015)
Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients
K. Kalinsky et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2015)
Circulating tumor cells in newly diagnosed inflammatory breast cancer
Michal Mego et al.
BREAST CANCER RESEARCH (2015)
Circulating tumor cells in non-metastatic triple-negative breast cancer
Mandar Karhade et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes
D. J. E. Peeters et al.
BRITISH JOURNAL OF CANCER (2014)
Clinical Validation of an Ultra High-Throughput Spiral Microfluidics for the Detection and Enrichment of Viable Circulating Tumor Cells
Bee Luan Khoo et al.
PLOS ONE (2014)
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination
Mario Giuliano et al.
BREAST CANCER RESEARCH (2014)
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
Francois-Clement Bidard et al.
CANCER AND METASTASIS REVIEWS (2013)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Heterogeneity of Estrogen Receptor Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients
Anna Babayan et al.
PLOS ONE (2013)
Isolation and retrieval of circulating tumor cells using centrifugal forces
Han Wei Hou et al.
SCIENTIFIC REPORTS (2013)
Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy
A. Giordano et al.
ANNALS OF ONCOLOGY (2012)
Epithelial-Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer
Antonio Giordano et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Circulating tumour cells in non-metastatic breast cancer: a prospective study
Anthony Lucci et al.
LANCET ONCOLOGY (2012)
HER2-Positive Circulating Tumor Cells in Breast Cancer
Michail Ignatiadis et al.
PLOS ONE (2011)
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
Mario Giuliano et al.
BREAST CANCER RESEARCH (2011)
Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer
F. -C. Bidard et al.
ANNALS OF ONCOLOGY (2010)
Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies
Mitra Tewes et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients
Nan Soon Wong et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
Daniel F. Hayes et al.
CLINICAL CANCER RESEARCH (2006)
Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer
M Cristofanilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
